“I’M NOT A MEDICAL DOCTOR” — THE RECORDED MEETING WITH WELLBEING’S CHIEF SCIENTIST (Part 1)

February 13, 2026

Share this article

Undercover footage raises fresh questions about who is advising patients at a Harley Street stem-cell venture.

Two panels: Blurred man at table. Text:

As scrutiny grows around the financial structures behind Wellbeing International Foundation, a new development in this investigation shifts the spotlight onto one of the organisation’s most visible scientific figures.


During a face-to-face meeting recorded on video, Stephen Ray, described by the company as a Chief Scientist, acknowledged that he is not a medical doctor — despite being involved in discussions with individuals exploring regenerative treatments linked to the organisation.

The recording forms part of a wider und

ercover investigation examining how prospective clients are introduced to complex and controversial therapies.


THE MOMENT CAUGHT ON CAMERA


In the opening moments of the recorded exchange, an undercover investigator asked Ray directly:


UC: “Are you a medical doctor?”
SR:
 “No, I’m a PhD doctor.”

When pressed further, Ray described himself as a neuroscientist and confirmed that he does not carry out medical procedures.


“I don’t do the medical treatment because I’m not a doctor,” he stated during the conversation.

The distinction between academic doctorates and licensed medical practitioners is widely understood within healthcare regulation — but critics say the difference may not always be clear to vulnerable clients seeking treatment.


“I’M THE CHIEF SCIENTIST”


Throughout the meeting, Ray repeatedly framed his role as scientific rather than clinical.


He explained that his job was to discuss the science behind the therapies and advise individuals about what the treatment might or might not achieve, while emphasising that final medical decisions were not his responsibility.


“My job is really to explain the science to them,” he said in the recording.

The exchange raises broader questions about how companies operating from prestigious medical districts — including London’s Harley Street — present expertise to the public.


QUESTIONS ABOUT QUALIFICATIONS


During the conversation, the undercover investigator challenged Ray on whether people might assume he was medically qualified due to his public-facing role.


Ray responded by reiterating that he holds a PhD rather than a medical licence.


Regulatory experts say this distinction is significant because UK medical law places strict boundaries around who can diagnose, treat, or present therapies as clinical interventions.


At no point in the recording does Ray claim to be a licensed medical practitioner.


HOW THE TREATMENT WAS DESCRIBED


In one of the most detailed sections of the exchange, Ray outlined how the procedure works from his perspective:

  • Blood is taken from the patient.
  • Samples are sent to a laboratory in Germany.
  • The material is later returned and reintroduced into the patient’s arm.


He described the process as involving “secretions that come off the stem cells,” rather than traditional stem-cell transplantation.


When asked directly whether he believed the process treats people, Ray responded:


“Yes it does… based on the research we’ve actually done.”

He also stated that he had spent decades developing the scientific approach behind the work.


COMPANY STRUCTURE AND LOCATION


During the meeting, Ray confirmed that the company connected to the treatments is registered in Bermuda — a detail that has previously raised questions among critics about corporate oversight and jurisdiction.

When asked why the structure was based there, Ray said:


“Max has got various business interests over there… I just deal with the science.”

A GROWING INVESTIGATION


This recording forms part of a broader inquiry into the individuals and financial structures surrounding Wellbeing International Foundation.


The investigation has already revealed a complex network of business relationships, offshore registrations, and historic corporate controversies linked to senior figures connected to the organisation.



Ray declined to speculate on allegations relating to colleagues or legal proceedings involving others, stating that his focus remained solely on scientific matters.

Recent Posts

May 15, 2026
For months, investigators have examined the digital footprint, corporate structure, public marketing, and leadership profiles connected to Wellbeing International Foundation Ltd.
May 15, 2026
As investigators continued examining the structure behind Wellbeing International Foundation Ltd,
May 10, 2026
WELLBEING INTERNATIONAL FOUNDATION TESTIMONIALS
May 10, 2026
WELLBEING INTERNATIONAL FOUNDATION LTD: “ETHICAL HEALING”
May 3, 2026
The commercial stem cell industry has grown rapidly over the past decade, with clinics around the world advertising regenerative medicine programs for conditions ranging from chronic pain to neurological disorders. Among the most controversial areas is autism. Families searching online are now routinely exposed to clinics promoting stem cell therapies as potential solutions for behavioural, developmental, or communication difficulties associated with autism spectrum disorder (ASD). But according to major medical authorities, parents should be extremely careful before committing to expensive experimental treatments. No Major Regulator Has Approved Stem Cell Therapy For Autism At present: The U.S. Food and Drug Administration has not approved stem cell therapy as a treatment for autism. The National Health Service does not recognise stem cell therapy as a standard autism treatment. European regulators continue treating most autism-related stem cell therapies as experimental. Researchers continue studying the field. But experimental science and established medical treatment are not the same thing. The Problem With Commercial Marketing Critics argue that some clinics blur the line between scientific possibility and proven outcome. Common marketing techniques include: Emotional recovery stories Before-and-after videos Technical medical language Claims of “advanced” therapy References to inflammation or neurological repair However, many scientists say evidence supporting these claims remains limited or inconclusive. Understanding Autism Complexity Autism is not a single illness. It is a broad developmental spectrum involving: Communication differences Behavioural traits Sensory variation Neurological diversity Because autism naturally develops differently in every child, measuring treatment success becomes highly complicated. Experts warn that developmental progress may sometimes occur naturally over time regardless of experimental intervention. What Treatments Have Better Scientific Support? While no treatment cures autism, specialists generally recommend evidence-based support approaches such as: Speech and language therapy Occupational therapy Behavioural intervention Educational support Social development programs Family support services Major organisations providing evidence-based information include: National Autistic Society https://www.autism.org.uk/ Centers for Disease Control and Prevention https://www.cdc.gov/autism/ World Health Organization https://www.who.int/ Autism Speaks https://www.autismspeaks.org/ Questions Families Should Ask Before Paying Experts recommend parents ask: Is this treatment regulator-approved? What peer-reviewed evidence exists? What are the known risks? What percentage of patients show no benefit? Are claims independently verified?  Evidence Before Emotion Families searching for hope deserve compassion, transparency, and honesty. Stem cell science remains an active research field. But until stronger clinical evidence exists, many experts believe autism-related stem cell treatments should be approached with serious caution — particularly when large sums of money and vulnerable families are involved.
May 3, 2026
As commercial stem cell clinics continue expanding across Europe and beyond, increasing numbers of families affected by autism are being introduced to expensive regenerative medicine programs marketed as cutting-edge alternatives to conventional therapy. One organisation repeatedly mentioned during conversations with former clients and concerned families is Wellbeing International Foundation LTD. This article does not accuse the clinic of criminal behaviour or fraud. However, as concerns surrounding commercial autism-related stem cell treatments continue growing internationally, experts say families should approach all such clinics with careful scrutiny. Why Autism Has Become A High-Interest Market Autism spectrum disorder affects millions of families worldwide. Because there is no single cure — and because developmental progress can vary enormously from child to child — families are often vulnerable to treatments marketed as innovative or revolutionary. Investigators reviewing the regenerative medicine sector have identified repeated themes in clinic advertising: Hope-based messaging Emotional testimonials Scientific jargon “Breakthrough” language Claims of advanced neurological repair Large financial commitments For many parents, distinguishing between genuine science and commercial optimism can become extremely difficult. THE MAIN WARNING SIGNS 🚩 Clinics Suggesting One Treatment Can Help Many Conditions Experts urge caution when the same therapy is promoted for: Autism Neurological disease Chronic pain Anti-ageing Immune conditions Degenerative illness Complex medical conditions require highly specific evidence. 🚩 Testimonials Used As Primary Evidence Powerful personal stories can influence emotions deeply. But regulators repeatedly warn that testimonials alone do not prove clinical effectiveness. 🚩 Scientific Terminology Without Clear Proof Families should ask clinics to clearly explain: How treatments work What evidence exists What outcomes are independently verified Complicated language is not the same as scientific certainty. 🚩 Significant Financial Commitments Many families report spending very large sums on: Consultations Treatment programs Flights Accommodation Repeat procedures without guaranteed outcomes. 🚩 Overseas Structures And Limited Oversight International treatment arrangements can complicate: Legal accountability Consumer rights Medical regulation Long-term follow-up The Ethics Of Hope Medical ethics experts have increasingly raised concerns about the emotional vulnerability of families searching for autism support. Parents naturally want to help their children. That emotional reality can make high-promise treatments especially persuasive. Critics argue that hope should never be marketed in a way that risks creating unrealistic expectations.  Questions Families Should Always Ask Before committing to any stem cell-based autism treatment, families should request: Published evidence Independent clinical data Long-term outcomes Full risk disclosures Regulatory status information Transparency matters. Especially when vulnerable families are involved.
May 3, 2026
For many parents raising children with autism, life becomes a constant search for answers. Therapies. Specialists. Diets. Support groups. New research. Alternative medicine. And increasingly, stem cell clinics. Over recent months, Investigations Desk has spoken with families who say they pursued expensive regenerative medicine treatments for autistic children after being exposed to persuasive marketing campaigns promising potential improvements in communication, behaviour, focus, and cognitive function. One parent — who we will identify only as Mr X to protect the child’s privacy — described a journey that began with optimism but eventually turned into doubt. According to Mr X, the family underwent multiple treatment procedures after being encouraged to believe stem cell-based therapies could potentially assist with autism-related symptoms. Initially, every small behavioural change felt significant. But over time, the family says they began questioning whether the treatments had actually produced any measurable improvement at all. “You want to believe something is happening,” Mr X explained. “As a parent, you analyse every little change because you desperately want your child to improve.” The family says the emotional pressure surrounding the process made objective judgment increasingly difficult. The Rise Of Autism As A Commercial Treatment Market Autism spectrum disorder has become one of the fastest-growing target areas within the global regenerative medicine industry. Across websites and social media platforms, clinics frequently advertise: Stem cell therapy Exosome therapy Neuro-regenerative medicine Immune modulation programs Cellular repair treatments Many use emotional testimonials alongside highly technical scientific language which can be difficult for ordinary families to independently verify. Investigators examining this sector have repeatedly identified recurring marketing patterns: Dramatic recovery stories Scientific terminology with limited explanation Expensive treatment packages Overseas treatment arrangements “Breakthrough” medical language Claims that conventional medicine is “behind” What Science Currently Says Despite aggressive online marketing, there is currently no universally accepted regulator-approved stem cell cure for autism. Research into stem cells and neurological conditions does exist. However, leading experts continue warning that experimental research should not be confused with established medical treatment. Autism itself is an extremely complex developmental condition involving a broad spectrum of behavioural and neurological differences. That complexity makes it particularly difficult to scientifically measure treatment claims being promoted commercially. Hope And Vulnerability Parents affected by autism are not foolish for exploring possibilities. They are hopeful. And hope can become extremely powerful when families feel conventional support systems are slow, limited, or overwhelmed. Critics of the commercial stem cell industry argue that some clinics may unintentionally blur the line between experimental science and proven medical outcomes. That concern is now drawing increasing international attention from regulators, scientists, and consumer protection groups.  The Bigger Question Mr X says the family eventually decided to speak privately with investigators after recognising similarities between their experience and concerns now being raised globally about commercial regenerative medicine businesses. “We’re not against research,” he said. “But families need to know the difference between evidence and hope.” That distinction may now sit at the heart of one of the most controversial debates in modern alternative medicine.
April 24, 2026
There is a pattern. Once you’ve seen it, you can’t unsee it.
Show More